Home › Stocks › TRDA › All Fund Holders
TRDA — ENTRADA THERAPEUTICS INC · All Fund Holders
Funds holding (latest): 40 · Reported value held: $91.19M
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 2.58M | $19.01M | 0.00% | Add |
| Vanguard Group history | Q4 2025 | 1.63M | $16.78M | 0.00% | Add |
| Janus Henderson Group history | Q2 2025 | 1.52M | $10.21M | 0.01% | Reduce |
| Wellington Management Group history | Q2 2026 | 954.42K | $7.02M | 0.00% | Reduce |
| Millennium Management history | Q2 2026 | 763.96K | $5.62M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 717.43K | $5.28M | 0.00% | Add |
| AQR Capital Management history | Q2 2026 | 699.54K | $5.15M | 0.00% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 496.46K | $3.83M | 0.00% | New |
| Citadel Advisors history | Q2 2026 | 394.32K | $2.90M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 309.94K | $2.28M | 0.00% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 197.14K | $1.45M | 0.00% | Reduce |
| Morgan Stanley history | Q2 2026 | 191.65K | $1.41M | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 191.00K | $1.41M | 0.00% | Reduce |
| Goldman Sachs Group history | Q2 2026 | 177.34K | $1.31M | 0.00% | Reduce |
| Moore Capital Management history | Q2 2026 | 105.00K | $772.80K | 0.01% | Hold |
| Arrowstreet Capital history | Q2 2025 | 102.01K | $685.49K | 0.00% | Reduce |
| Marshall Wace history | Q1 2026 | 53.76K | $678.50K | 0.00% | Add |
| Royce & Associates history | Q2 2026 | 82.90K | $610.16K | 0.01% | Reduce |
| MFS Investment Management history | Q2 2025 | 87.39K | $587.24K | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 79.07K | $581.96K | 0.00% | Add |
| Manulife Financial history | Q2 2026 | 72.52K | $533.75K | 0.00% | Add |
| Bank of America Corp history | Q2 2026 | 57.93K | $426.34K | 0.00% | Add |
| Two Sigma Investments history | Q2 2026 | 46.40K | $341.52K | 0.00% | Add |
| Invesco Ltd history | Q2 2026 | 44.34K | $326.37K | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 41.56K | $305.91K | 0.00% | Add |
| D. E. Shaw & Co history | Q2 2026 | 32.40K | $238.44K | 0.00% | Reduce |
| CPP Investments history | Q1 2026 | 17.70K | $223.37K | 0.00% | Reduce |
| Point72 Asset Management history | Q2 2026 | 28.50K | $209.76K | 0.00% | New |
| Deutsche Bank AG history | Q2 2026 | 26.56K | $195.45K | 0.00% | Add |
| Prudential Financial history | Q2 2025 | 28.34K | $190.44K | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 24.90K | $183.28K | 0.00% | Add |
| Balyasny Asset Management history | Q4 2025 | 14.02K | $144.09K | 0.00% | New |
| Franklin Resources history | Q1 2026 | 11.10K | $140.11K | 0.00% | New |
| Citigroup Inc history | Q2 2026 | 14.79K | $108.85K | 0.00% | Add |
| Legal & General Investment Management America history | Q2 2026 | 2.56K | $18.81K | 0.00% | Hold |
| Fidelity Management & Research (FMR) history | Q2 2026 | 2.17K | $15.96K | 0.00% | Reduce |
| PNC Financial Services history | Q2 2026 | 1.14K | $8.35K | 0.00% | Reduce |
| T. Rowe Price Associates history | Q2 2026 | 542.32K | $3.99K | 0.00% | Add |
| Amundi US history | Q1 2025 | 12 | $96 | 0.00% | Reduce |
| Lazard Asset Management history | Q2 2025 | 1.26K | $8 | 0.00% | Reduce |